¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"percent surface dose"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
percent labeled mitosis technique
¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿¹ý
approximal surface
Á¢Ã˸é, ÀÎÁ¢¸é
articular surface
°üÀý¸é
body surface mapping
üǥ¸éÀüÀ§Áöµµ
cardiac surface map
½ÉÀåÇ¥¸éµµ
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
dorsal surface
µîÂʸé, µÞ¸é, ¹èÃø¸é
fetal surface
žÆ(ÂÊ)¸é
free surface
ÀÚÀ¯¸é
hepatitis B surface antigen
BÇü°£¿°Ç¥¸éÇ׿ø
internal surface
¼Ó¸é, ³»¸é
lateral surface
°¡Âʸé, ¿ÜÃø¸é, Ãø¸é
occlusal surface
±³ÇÕ¸é, ¸Â¹°¸²¸é
potential surface
ÀüÀ§¸é
proximate surface
ÀÎÁ¢¸é
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
surface antigen
Ç¥¸éÇ׿ø
surface area
üǥ¸éÀû, Ç¥¸éÀû
surface coil
Ç¥¸éÄÚÀÏ, Ç¥¸é°ËÃâ±â
surface characteristic
Ç¥¸éƯ¼º
surface electrode
Ç¥¸éÀü±Ø
surface
Ç¥¸é, ¸é
articular surface
°üÀý¸é
dorsal surface
µîÂʸé, µÞ¸é
lateral surface
°¡Âʸé, ¿ÜÃø¸é
potential surface
ÀüÀ§¸é
proximate surface
ÀÎÁ¢¸é
surface tension
Ç¥¸éÀå·Â
dose
¿ë·®, Åõ¿©·®, ¹æ»ç¼±·®
average dose
Æò±Õ¿ë·®, Æò±Õ¼±·®
booster dose
Ãß°¡Á¢Á¾·®, Ãß°¡¿ë·®
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
percent labeled mitosis technique
¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿¹ý
percent reactive antibody test
¹éºÐÀ²¹ÝÀÀÇ×ü°Ë»ç
anterolateral surface
¾Õ°¡Âʸé
anteromedial surface
¾Õ¾ÈÂʸé
approximal surface
Á¢Ã˸é
articular surface
°üÀý¸é
hepatitis B surface antigen
ºñÇü°£¿°Ç¥¸éÇ׿ø
surface anesthesia
Ç¥¸é¸¶Ãë
surface antigen
Ç¥¸éÇ׿ø
surface area
üǥ¸éÀû, Ç¥¸éÀû
surface refrigeration anesthesia
Ç¥¸é³Ãµ¿¸¶Ãë
body surface mapping
üǥ¸éÀüÀ§µµ
cardiac surface map
½ÉÀåÇ¥¸éµµ
cell surface receptor
¼¼Æ÷Ç¥¸é¼ö¿ëü
root surface cavity
À̻Ѹ®¸é°ø°£
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
gram percent
±×·¥¹éºÐÀ²(¡ÛÝÝÂëÒ).
ED 50=£¾effective dose 50%
50% À¯È¿·®, Áß°£À¯È¿·®.
ED 50=£¾effective dose 50%
50% À¯È¿·®.
ED 50=ÊÝeffective dose 50%
50% À¯È¿·®.
ED=ÊÝeffective dose
À¯È¿·®.
ID50 (50% infectious dose)
50% °¨¿°·®
LD = lethal dose
Ä¡»ç·®.
LD50 (50% lethal dose)
50% Ä¡»ç·®
LD= lethal dose
Ä¡»ç·®.
MED => minimum effective dose
ÃÖ¼ÒÈ«¹Ý·®
MED=> minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MED=£¾minimum effective dose
ÃÖ¼ÒÀ¯È¿·®.
MTD=> maximum toderance dose
ÃÖ´ë³»¿ë·®.
MTD=£¾maximum tolerance dose
ÃÖ´ë³»¿ë·®.
MTD=ÊÝmaximum toderance dose
ÃÖ´ë³»¿ë·®.
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
percent surface dose
Ç¥¸é¼±·®¹éºÐÀ²
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
gram percent
±×·¥¹éºÐÀ²(¡ÛÝÝÂëÒ).
percent labeled mitoses technique
¹éºÐÀ²Ç¥ÁöÀ¯»çºÐ¿¹ý
percent reactive antibody test
ÆÛ¼¾Æ®¹ÝÀÀ(Úãëë)Ç×ü°Ë»ç
volume percent
¿ëÀû¹éºÐÀ²(é»îÝÛÝÝÂëÒ).
volume percent
¿ëÀû¹éºÐÀ²(é»îÝÛÝÝÂëÒ)
weight/volume percent
üÁß/¿ëÀû ·ü
weight/weight percent
üÁß/üÁß ·ü
cumulative dose ; cumulate dose
´©Àû¿ë·®.
cumulative dose ; cumulate dose
ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® , [¿¹¹æ] ÁýÀû¼±·®.
cumulative dose ; cumulate dose
ÃàÀû(¿ë)·®, ´©Àû(¿ë)·®, ´©ÀûÁ¶»ç(¿ë)·® .[¿¹¹æ]ÁýÀû¼±·®.
dose rate ; dosage rate ; dose per unit time
¹æ»ç ÀÓº´,ÇÙÀÇ,¾à¸®¼±·®·ü, ¿ë·®.
optimal dose ; optimum dose
ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
optimal dose ; optimum dose
¹æ»ç [¾à¸®,ÇØºÎ,¿¹¹æ]ÃÖÀû·®, ÀûÁ¤·®(ËøËøËâ).
optimal dose ; optimum dose
ÃÖÀû·®, ÀûÁ¤·®(îêïáåÖ).
surface absorbed dose
Ç¥¸éÈí¼ö¼±·®
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½